SL Science Holding Limited Ordinary Shares (SLBT) stock: key figures, P/E, revenue and dividend

Health Care · Biotechnology · United States · ISIN KYG8191L1169

Price
0.90 USD
Market cap
504.68 m USD
P/E (2025)
–
P/S (2025)
229.69
Dividend yield
0.00 %
Net margin
-173.85 %
Return on equity (ROE)
-167.25 %
Return on assets (ROA)
-135.59 %

SL Science Holding Limited Ordinary Shares financials

Fiscal year20242025
Revenue3.36 m USD2.20 m USD
Gross profit1.93 m USD775,062.00 USD
Operating income-1.20 m USD-3.84 m USD
EBIT-1.20 m USD-3.84 m USD
Net income-1.19 m USD-3.82 m USD
Diluted EPS – continuing operations-0.00 USD-0.01 USD

Full history since 2023, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About SL Science Holding Limited Ordinary Shares

SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company's products include SL bio's milk-derived exosome essence, SL bio's tangerine-derived extract, and the MilkExo concentrate series. It also offers research services in armed T-cells, gamma delta T- cells, citrus reticulata (tangerine) extract, and milk-derived exosomes. SL Science Holding Limited was formerly known as SL BIO Co., Ltd. and changed its name to SL Science Holding Limited in June 2026. The company is based in Taipei, Taiwan.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 05.11.2026. Details in the risk notice.